Cardiomyopathy reverses with recovery of liver injury, cholestasis and cholanemia in mouse model of biliary fibrosis

Publisher： John Wiley & Sons Inc

E-ISSN： 1478-3231|35|4|1464-1477

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.35, Iss.4, 2015-04, pp. : 1464-1477

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dual farnesoid X receptor/TGR5 agonist INT‐767 reduces liver injury in the Mdr2−/− (Abcb4−/−) mouse cholangiopathy model by promoting biliary HCO 3− output

By  

HEPATOLOGY, Vol. 54, Iss. 4, 2011-10 ,pp. : 1303-1312

John Wiley & Sons Inc

Access to resources Recommend Favorite

Growth hormone resistance exacerbates cholestasis‐induced murine liver fibrosis

By  

HEPATOLOGY, Vol. 61, Iss. 2, 2015-02 ,pp. : 613-626

John Wiley & Sons Inc

Access to resources Recommend Favorite

The pan‐caspase inhibitor Emricasan (IDN‐6556) decreases liver injury and fibrosis in a murine model of non‐alcoholic steatohepatitis

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 3, 2015-03 ,pp. : 953-966

John Wiley & Sons Inc

Access to resources Recommend Favorite

Alpha‐1 antitrypsin Z protein (PiZ) increases hepatic fibrosis in a murine model of cholestasis

By  

HEPATOLOGY, Vol. 46, Iss. 5, 2007-11 ,pp. : 1443-1452

John Wiley & Sons Inc

Access to resources Recommend Favorite

Noninvasive elastography‐based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis

By  

HEPATOLOGY, Vol. 56, Iss. 1, 2012-07 ,pp. : 198-208

John Wiley & Sons Inc

Access to resources Recommend Favorite